How to buy CME Group stock | $163.34

CME Group Inc is a financial data & stock exchanges business based in the US. CME Group shares (CME) are listed on the NASDAQ and all prices are listed in US Dollars. CME Group employs 4,360 staff and has a trailing 12-month revenue of around USD$4.9 billion.

How to buy shares in CME Group

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for CME Group. Find the stock by name or ticker symbol: CME. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CME Group reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$163.34, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of CME Group, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of CME Group. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

CME Group share price

Use our graph to track the performance of CME stocks over time.

CME Group shares at a glance

• Key figures

Information last updated 2020-12-26.

Latest market close	USD$163.34
52-week range	USD$128.1415 - USD$218.2431
50-day moving average	USD$174.9029
200-day moving average	USD$169.4749
Wall St. target price	USD$175.58
PE ratio	29.7467
Dividend yield	USD$3.4 (1.9%)
Earnings per share (TTM)	USD$6

Buy CME Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy CME Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of CME Group Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CME Group price performance over time

Historical closes compared with the close of $163.34 from 2020-10-19

1 week (2021-01-08)	-18.20%
1 month (2020-12-15)	-9.95%
3 months (2020-10-15)	-2.24%
6 months (2020-07-15)	-3.25%

1 year (2020-01-15)	-20.33%
2 years (2019-01-15)	-10.23%
3 years (2018-01-12)	6.95%
5 years (2016-01-15)	92.82%

Is CME Group under- or over-valued?

Valuing CME Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CME Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CME Group's P/E ratio

CME Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, CME Group shares trade at around 30x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

CME Group's PEG ratio

CME Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.1874. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CME Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

CME Group's EBITDA

CME Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$3.2 billion.

The EBITDA is a measure of a CME Group's overall financial performance and is widely used to measure a its profitability.

CME Group financials

Revenue TTM	USD$4.9 billion
Operating margin TTM	56.28%
Gross profit TTM	USD$4.9 billion
Return on assets TTM	1.68%
Return on equity TTM	7.99%
Profit margin	43.8%
Book value	$75.355
Market capitalisation	USD$64.1 billion

TTM: trailing 12 months

Shorting CME Group shares

There are currently 5.2 million CME Group shares held short by investors – that's known as CME Group's "short interest". This figure is 7.2% down from 5.7 million last month.

There are a few different ways that this level of interest in shorting CME Group shares can be evaluated.

CME Group's "short interest ratio" (SIR)

CME Group's "short interest ratio" (SIR) is the quantity of CME Group shares currently shorted divided by the average quantity of CME Group shares traded daily (recently around 1.4 million). CME Group's SIR currently stands at 3.69. In other words for every 100,000 CME Group shares traded daily on the market, roughly 3690 shares are currently held short.

However CME Group's short interest can also be evaluated against the total number of CME Group shares, or, against the total number of tradable CME Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CME Group's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 CME Group shares in existence, roughly 20 shares are currently held short) or 0.0181% of the tradable shares (for every 100,000 tradable CME Group shares, roughly 18 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CME Group.

Find out more about how you can short CME Group stock.

CME Group's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CME Group.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

CME Group's total ESG risk score

Total ESG risk: 16.2

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CME Group's overall score of 16.2 (as at 01/01/2019) is excellent – landing it in it in the 10th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like CME Group is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

CME Group's environmental score

Environmental score: 6.41/100

CME Group's environmental score of 6.41 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

CME Group's social score

Social score: 9.64/100

CME Group's social score of 9.64 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

CME Group's governance score

Governance score: 8.65/100

CME Group's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CME Group is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

CME Group's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. CME Group scored a 1 out of 5 for controversy – the highest score possible, reflecting that CME Group has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

CME Group Inc was last rated for ESG on: 2019-01-01.

Total ESG score	16.2
Total ESG percentile	9.8
Environmental score	6.41
Environmental score percentile	5
Social score	9.64
Social score percentile	5
Governance score	8.65
Governance score percentile	5
Level of controversy	1

CME Group share dividends

Dividend payout ratio: 73.62% of net profits

Recently CME Group has paid out, on average, around 73.62% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.9% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CME Group shareholders could enjoy a 1.9% return on their shares, in the form of dividend payments. In CME Group's case, that would currently equate to about $3.4 per share.

CME Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

CME Group's most recent dividend payout was on 13 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 24 December 2020 (the "ex-dividend date").

Have CME Group's shares ever split?

CME Group's shares were split on a 5:1 basis on 23 July 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your CME Group shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for CME Group shares which in turn could have impacted CME Group's share price.

CME Group share price volatility

Over the last 12 months, CME Group's shares have ranged in value from as little as $128.1415 up to $218.2431. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CME Group's is 0.4798. This would suggest that CME Group's shares are less volatile than average (for this exchange).

CME Group overview

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions. The company also provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services; and transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, regulatory reporting, and trade processing. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company has strategic partnership with B3 S.A. to develop risk management products for Brazilian domestic and international market participants. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Frequently asked questions

• What percentage of CME Group is owned by insiders or institutions?

  Currently 1.388% of CME Group shares are held by insiders and 86.964% by institutions.

• How many people work for CME Group?

  Latest data suggests 4,360 work at CME Group.

• When does the fiscal year end for CME Group?

  CME Group's fiscal year ends in December.

• Where is CME Group based?

  CME Group's address is: 20 South Wacker Drive, Chicago, IL, United States, 60606

• What is CME Group's ISIN number?

  CME Group's international securities identification number is: US12572Q1058

• What is CME Group's CUSIP number?

  CME Group's Committee on Uniform Securities Identification Procedures number is: 12572Q105